152 related articles for article (PubMed ID: 30308704)
1. Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway.
Li Y; Zhang J; Zhou Q; Wang H; Xie S; Yang X; Ji P; Zhang W; He T; Liu Y; Wang K; Li X; Shi J; Hu D
Exp Dermatol; 2019 Jan; 28(1):19-27. PubMed ID: 30308704
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway.
Li Y; Zhang W; Gao J; Liu J; Wang H; Li J; Yang X; He T; Guan H; Zheng Z; Han S; Dong M; Han J; Shi J; Hu D
Stem Cell Res Ther; 2016 Aug; 7(1):102. PubMed ID: 27484727
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.
Mu S; Kang B; Zeng W; Sun Y; Yang F
Mol Cell Biochem; 2016 May; 416(1-2):99-108. PubMed ID: 27075467
[TBL] [Abstract][Full Text] [Related]
4. p75NTR silencing inhibits proliferation, migration, and extracellular matrix deposition of hypertrophic scar fibroblasts by activating autophagy through inhibiting the PI3K/Akt/mTOR pathway.
Shi W; Wu Y; Bian D
Can J Physiol Pharmacol; 2021 Apr; 99(4):349-359. PubMed ID: 32726570
[TBL] [Abstract][Full Text] [Related]
5. IL10 inhibits starvation-induced autophagy in hypertrophic scar fibroblasts via cross talk between the IL10-IL10R-STAT3 and IL10-AKT-mTOR pathways.
Shi J; Wang H; Guan H; Shi S; Li Y; Wu X; Li N; Yang C; Bai X; Cai W; Yang F; Wang X; Su L; Zheng Z; Hu D
Cell Death Dis; 2016 Mar; 7(3):e2133. PubMed ID: 26962683
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ANGPT2 activates autophagy during hypertrophic scar formation via PI3K/AKT/mTOR pathway.
Chen H; Xu K; Sun C; Gui S; Wu J; Wang S
An Bras Dermatol; 2023; 98(1):26-35. PubMed ID: 36272879
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring.
Li Y; Shi S; Gao J; Han S; Wu X; Jia Y; Su L; Shi J; Hu D
Biomed Pharmacother; 2016 May; 80():80-86. PubMed ID: 27133042
[TBL] [Abstract][Full Text] [Related]
8. [Emodin inhibits the proliferation, transdifferentiation and collagen synthesis of pulmonary fibroblasts].
Liu L; Yin H; He J; Xie M; Wang Z; Xiao H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):921-5. PubMed ID: 27363273
[TBL] [Abstract][Full Text] [Related]
9. Melatonin inhibits fibroblast cell functions and hypertrophic scar formation by enhancing autophagy through the MT2 receptor-inhibited PI3K/Akt /mTOR signaling.
Dong Y; Cao X; Huang J; Hu Z; Chen C; Chen M; Long Q; Xu Z; Lv D; Rong Y; Luo S; Wang H; Deng W; Tang B
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166887. PubMed ID: 37739092
[TBL] [Abstract][Full Text] [Related]
10. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of sphingosine kinase 2 attenuates hypertrophic scar formation via upregulation of Smad7 in human hypertrophic scar fibroblasts.
Zeng J; Jiang B; Xiao X; Zhang R
Mol Med Rep; 2020 Sep; 22(3):2573-2582. PubMed ID: 32705254
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-130a has pro-fibroproliferative potential in hypertrophic scar by targeting CYLD.
Zhang J; Zhou Q; Wang H; Huang M; Shi J; Han F; Cai W; Li Y; He T; Hu D
Arch Biochem Biophys; 2019 Aug; 671():152-161. PubMed ID: 31283910
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue-derived stem cells inhibit hypertrophic scar (HS) fibrosis via p38/MAPK pathway.
Chai CY; Song J; Tan Z; Tai IC; Zhang C; Sun S
J Cell Biochem; 2019 Mar; 120(3):4057-4064. PubMed ID: 30260015
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function.
Li SY; Fang CX; Aberle NS; Ren BH; Ceylan-Isik AF; Ren J
J Endocrinol; 2005 Sep; 186(3):491-503. PubMed ID: 16135669
[TBL] [Abstract][Full Text] [Related]
15. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.
Jung KH; Ryu YL; Lee HS; Lee H; Son MK; Yan HH; Hong SW; Ryu JK; Hong S; Suh JK; Hong SS
Int J Oncol; 2013 Jun; 42(6):2001-8. PubMed ID: 23588860
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
[TBL] [Abstract][Full Text] [Related]
17. miR-155 inhibits the formation of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT pathway.
Wu X; Li J; Yang X; Bai X; Shi J; Gao J; Li Y; Han S; Zhang Y; Han F; Liu Y; Li X; Wang K; Zhang J; Wang Z; Tao K; Hu D
J Mol Histol; 2018 Aug; 49(4):377-387. PubMed ID: 29785488
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1.
Li Y; Zhang J; Zhang W; Liu Y; Li Y; Wang K; Zhang Y; Yang C; Li X; Shi J; Su L; Hu D
J Mol Histol; 2017 Dec; 48(5-6):357-366. PubMed ID: 28884252
[TBL] [Abstract][Full Text] [Related]
19. Ozone oil promotes wound healing by increasing the migration of fibroblasts via PI3K/Akt/mTOR signaling pathway.
Xiao W; Tang H; Wu M; Liao Y; Li K; Li L; Xu X
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28864782
[TBL] [Abstract][Full Text] [Related]
20. Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway.
Wang EM; Fan QL; Yue Y; Xu L
Med Sci Monit; 2018 Feb; 24():846-854. PubMed ID: 29428962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
